vs
ASP Isotopes Inc.(ASPI)与SS Innovations International, Inc.(SSII)财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是SS Innovations International, Inc.的1.1倍($16.7M vs $14.5M),ASP Isotopes Inc.同比增速更快(1295.7% vs 79.1%),SS Innovations International, Inc.自由现金流更多($-3.2M vs $-47.4M)
ASP Isotopes Inc.是一家特种材料企业,专注于高纯度定制同位素的研发与生产,产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域,客户覆盖北美、欧洲及亚太地区。
SS Innovations International, Inc.是一家全球化医疗科技企业,专注于研发、生产创新型外科手术机器人系统,为多地区医疗机构提供高精度、易获取的微创手术机器人平台,致力于提升手术效果、减轻手术操作负担。
ASPI vs SSII — 直观对比
营收规模更大
ASPI
是对方的1.1倍
$14.5M
营收增速更快
ASPI
高出1216.6%
79.1%
自由现金流更多
SSII
多$44.2M
$-47.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.7M | $14.5M |
| 净利润 | — | $-2.5M |
| 毛利率 | 12.5% | 43.9% |
| 营业利润率 | — | -3.7% |
| 净利率 | — | -17.0% |
| 营收同比 | 1295.7% | 79.1% |
| 净利润同比 | -586.8% | -28.5% |
| 每股收益(稀释后) | — | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASPI
SSII
| Q4 25 | $16.7M | $14.5M | ||
| Q3 25 | $4.9M | $12.8M | ||
| Q2 25 | — | $10.0M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $3.6M |
净利润
ASPI
SSII
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-12.9M | $-3.7M | ||
| Q2 25 | — | $-256.7K | ||
| Q1 25 | — | $-5.7M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $-3.2M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | $-9.8M |
毛利率
ASPI
SSII
| Q4 25 | 12.5% | 43.9% | ||
| Q3 25 | 8.7% | 48.1% | ||
| Q2 25 | — | 59.1% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 48.9% | ||
| Q3 24 | — | 52.8% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 20.0% |
营业利润率
ASPI
SSII
| Q4 25 | — | -3.7% | ||
| Q3 25 | -306.1% | -14.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | -115.6% | ||
| Q4 24 | — | -22.7% | ||
| Q3 24 | — | -73.1% | ||
| Q2 24 | — | -90.9% | ||
| Q1 24 | — | -270.3% |
净利率
ASPI
SSII
| Q4 25 | — | -17.0% | ||
| Q3 25 | -263.7% | -29.0% | ||
| Q2 25 | — | -2.6% | ||
| Q1 25 | — | -111.0% | ||
| Q4 24 | — | -23.7% | ||
| Q3 24 | — | -74.0% | ||
| Q2 24 | — | -91.8% | ||
| Q1 24 | — | -270.5% |
每股收益(稀释后)
ASPI
SSII
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.15 | $-0.02 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $3.2M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $38.2M |
| 总资产 | $498.0M | $74.2M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势,按日历期对齐
现金及短期投资
ASPI
SSII
| Q4 25 | $333.3M | $3.2M | ||
| Q3 25 | $113.9M | $5.7M | ||
| Q2 25 | — | $11.4M | ||
| Q1 25 | — | $15.9M | ||
| Q4 24 | — | $466.5K | ||
| Q3 24 | — | $220.4K | ||
| Q2 24 | — | $608.2K | ||
| Q1 24 | — | $948.1K |
总债务
ASPI
SSII
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
ASPI
SSII
| Q4 25 | $204.2M | $38.2M | ||
| Q3 25 | $74.1M | $39.6M | ||
| Q2 25 | — | $42.0M | ||
| Q1 25 | — | $40.6M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | — | $13.7M | ||
| Q2 24 | — | $14.8M | ||
| Q1 24 | — | $16.7M |
总资产
ASPI
SSII
| Q4 25 | $498.0M | $74.2M | ||
| Q3 25 | $225.9M | $69.6M | ||
| Q2 25 | — | $70.0M | ||
| Q1 25 | — | $63.5M | ||
| Q4 24 | — | $42.4M | ||
| Q3 24 | — | $39.0M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | — | $35.2M |
负债/权益比
ASPI
SSII
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $-3.2M |
| 自由现金流率自由现金流/营收 | -284.7% | -22.3% |
| 资本支出强度资本支出/营收 | 57.9% | 11.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.2M |
8季度趋势,按日历期对齐
经营现金流
ASPI
SSII
| Q4 25 | $-37.8M | $-1.5M | ||
| Q3 25 | $-8.9M | $-7.5M | ||
| Q2 25 | — | $-3.5M | ||
| Q1 25 | — | $-6.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-2.7M |
自由现金流
ASPI
SSII
| Q4 25 | $-47.4M | $-3.2M | ||
| Q3 25 | $-12.0M | $-8.2M | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | — | $-7.0M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | — | $-3.1M | ||
| Q1 24 | — | $-2.8M |
自由现金流率
ASPI
SSII
| Q4 25 | -284.7% | -22.3% | ||
| Q3 25 | -245.5% | -64.1% | ||
| Q2 25 | — | -37.7% | ||
| Q1 25 | — | -136.2% | ||
| Q4 24 | — | -41.7% | ||
| Q3 24 | — | -96.9% | ||
| Q2 24 | — | -69.5% | ||
| Q1 24 | — | -76.9% |
资本支出强度
ASPI
SSII
| Q4 25 | 57.9% | 11.8% | ||
| Q3 25 | 64.4% | 5.9% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 38.8% | ||
| Q2 24 | — | 46.8% | ||
| Q1 24 | — | 3.5% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |